Clinical Trials Browser

Phase 1 × Active not recruiting × Metformin × Clear all

NCT03006172 2026-03-11

To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms

NCT06899061 2026-03-03

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Phase 1 Active not recruiting

Advanced Solid Malignancies

NCT02336087 2026-02-04

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Adenocarcinoma

NCT03889795 2025-10-20

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

Phase 1 Active not recruiting

GastrointestinalOther solid neoplasm

Advanced Pancreatic Cancer